Other Stories

Full Video

FDA authorizes Pfizer COVID-19 booster dose for kids ages 5 to 11 years old Updated: 2022-05-18 05:47:20 KST

The U.S. Food and Drug Administration on Tuesday, approved a third shot of Pfizer’s COVID-19 vaccine for children. aged 5 to 11 for administration at least five months after their first two-doses.
The decision comes as the FDA cited data, which showed that the protection provided by two shots wanes over time.
It also determined that a third shot can help boost protection for children in this age group.
The drug regulator did not identify any new safety concerns after its trials and found children experienced the same mild side effects that other people do after receiving a booster shot.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.